RxDoctor Payments Data

Matthew Stein, OD

Optometrist · Fargo, NDNPI 1205501095

Payments from drug & device makers

What this record shows

Alcon accounts for 67.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $1,489 and has fallen 92.7% since, to $109 in 2025. Among optometrist clinicians in ND with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,381in general payments, 2019–2025

Across 37 payments — averaging $64.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$2K
  • AbbVie$216
  • Amgen$190
  • Novartis$93
  • Sun Pharmaceutical Industries Inc.$86
  • Biotissue Holdings Inc.$78
  • plus $104 from 3 others

What the payments were for

  • Travel & lodging$96440%
  • Food & beverage$1,41760%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,381 in reported general payments places this provider in the 90th percentile of 179 optometrist providers in North Dakota.

See all optometrist providers in North Dakota

Medicare billing

Part B allowed, 2024
$21,775
Medicare patients
124
Services billed
1,413

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost139$1,928
Prednisolone Acetate19$1,125
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha38$494
Timolol Maleate29$204

Paid to pharmacies, not to this prescriber.

Other optometrist in Fargo

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →